Alpa Laboratories IPO GMP History
Alpa Laboratories IPO has been listed on August 6, 2007 at a listing price of ₹61, against the issue price of ₹68 — a loss of ₹7 (-10.29%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Alpa Laboratories IPO raised ₹61.07 Cr. through its IPO at a price band of ₹62 to ₹68 per share, with a lot size of 100 shares. The IPO was open for subscription from 12 Jul 2007 to 17 Jul 2007.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 8:15 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Alpa Laboratories IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 12 Jul 2007
- Close 17 Jul 2007
- Allotment 27 Jul 2007
- Refund/credit TBA
- Listing 06 Aug 2007
Alpa Laboratories IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹68 |
|---|---|
| Listing gain / loss | −₹7 per share |
| Listing date | 06 Aug, 2007 |
| Actual listing price | ₹61 (-10.29%) |
Is Alpa Laboratories IPO GMP reliable?
Grey market premium for Alpa Laboratories IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Alpa Laboratories IPO full review for a fundamentals-based assessment before making any grey market trades.
Alpa Laboratories IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Alpa Laboratories IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Alpa Laboratories IPO
Alpa Laboratories Limited was incorporated on 18 March 1988 as Alpa Laboratories Private Limited and has its registered office at Pigdamber, Indore. Its promoters include Purushottam R. Patel, Nayana J. Patel, M. S. Chawla, Paresh Chawla, Pravin C. Shah and members of the Shah family.
It makes ethical drugs, generic drugs, over the counter products and veterinary products in several dosage forms and sells them under the Alpa trade mark, which is registered in the name of a promoter group company.
It also makes formulations under their own brands for other drug companies such as Cipla, Zydus Cadila, Lupin and Glenmark, and exports to countries including the Philippines, Kenya, Ghana and Nigeria.
The IPO was Rs 61.07 crore and was entirely a fresh issue at Rs 68, the top of the Rs 62 to Rs 68 band. The money was mainly for a new plant at Pigdamber, Indore and for working capital margin.
Frequently asked
What is the GMP of Alpa Laboratories IPO?
The current Grey Market Premium (GMP) of Alpa Laboratories IPO is not yet started or active in the market.
What is the Kostak Price of Alpa Laboratories IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Alpa Laboratories IPO is not available.
What is the Subject to Sauda Price of Alpa Laboratories IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Alpa Laboratories IPO?
Alpa Laboratories IPO listed on August 6, 2007 at ₹61, against the issue price of ₹68 — a loss of -10.29%.
How did the GMP of Alpa Laboratories IPO trend before listing?
The GMP of Alpa Laboratories IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Alpa Laboratories IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
